Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically

Akinori Sato, Takako Asano, Keiichi Ito, Makoto Sumitomo, Tomohiko Asano

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint Dive into the research topics of 'Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically'. Together they form a unique fingerprint.

Medicine & Life Sciences